An aging population, an ever increasing amount of time viewing digital devices and a growing trend in eye diseases are all factors expected to fuel a global…

eteplirsen

FDA expert lashes out at 'worrisome' Sarepta approval in JAMA

FDA new drugs director slams Sarepta approval as ‘NOT a good model’